• $8.0M
    Market Cap
  • -41.00%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
3.9M
+20.35%
3.3M
+11.92%
2.9M
+323.73%
691,000
N/A
Cost of Revenue
1.6M
+1.28%
1.6M
-7.17%
1.7M
+26.65%
1.3M
N/A
Gross Profit
2.4M
+37.81%
1.7M
+37.87%
1.2M
+293.60%
-641,000
N/A
Sales and Marketing Expense
6.0M
+17.95%
5.1M
-24.62%
6.8M
-13.47%
7.8M
N/A
Research and Development Expense
-2.1M
-17.44%
-2.6M
-17.70%
-3.2M
+11.85%
-2.8M
N/A
Depreciation and Amortization Expense
262,000
-35.78%
408,000
+105.03%
199,000
+155.13%
78,000
N/A
Total Operating Expenses
15.2M
-2.11%
15.5M
-8.79%
17.0M
-6.17%
18.1M
N/A
Operating Profit
-12.8M
-7.08%
-13.8M
-12.47%
-15.7M
-16.01%
-18.7M
N/A
Interest Income
236,000
+28.96%
183,000
+9.58%
167,000
-7.22%
180,000
N/A
Interest Expense
N/A
N/A
N/A
N/A
-21,000
-94.07%
-354,000
N/A
Interest Income and Expense and Net
236,000
+28.96%
183,000
+25.34%
146,000
+183.91%
-174,000
N/A
Total Nonoperating Income and Expense
236,000
+153.76%
93,000
-36.30%
146,000
+176.04%
-192,000
N/A
Income before Taxes
-12.8M
-7.08%
-13.8M
-12.47%
-15.7M
-16.01%
-18.7M
N/A
Income Taxes
N/A
N/A
N/A
N/A
1,000
0.00%
1,000
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-12.6M
-8.17%
-13.7M
-12.25%
-15.6M
-17.63%
-18.9M
N/A
Net Income from Continuing Operations Applicable to Common
-12.6M
-8.17%
-13.7M
-12.25%
-15.6M
-17.63%
-18.9M
N/A
Basic EPS and Net Income
-1.70
-84.90%
-11.26
+31.08%
-8.59
+263.98%
-2.36
N/A
Diluted EPS and Net Income
-1.70
-84.90%
-11.26
+31.08%
-8.59
+263.98%
-2.36
N/A
Basic Weighted Average Shares
7,384
+508.24%
1,214
-33.08%
1,814
-77.35%
8,008
N/A
Diluted Weighted Average Shares
7,384
+508.24%
1,214
-33.08%
1,814
-77.35%
8,008
N/A
Balance Sheet
Cash and Cash Equivalents
3.8M
-42.52%
6.5M
+169.15%
2.4M
+14.04%
2.1M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
6.4M
N/A
Cash and Cash Equivalents and Short-Term Investments
3.8M
-42.52%
6.5M
+169.15%
2.4M
-71.67%
8.6M
N/A
Total Current Assets
6.8M
-17.56%
8.2M
+111.11%
3.9M
-58.39%
9.3M
N/A
Accumulated Depreciation
906,000
+35.63%
668,000
+144.69%
273,000
+241.25%
80,000
N/A
Property and Plant and Equipment and Net
918,000
+22.07%
752,000
-21.75%
961,000
+21.19%
793,000
N/A
Total Long-Term Assets
918,000
-22.40%
1.2M
-32.75%
1.8M
+115.04%
818,000
N/A
Total Assets
10.8M
+9.32%
9.8M
+55.13%
6.3M
-42.78%
11.1M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
717,000
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
1.2M
N/A
N/A
N/A
Total Current Liabilities
3.2M
+71.91%
1.9M
-40.48%
3.1M
+24.11%
2.5M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
141,000
0.00%
141,000
-67.06%
428,000
-37.34%
683,000
N/A
Total Liabilities
5.7M
+47.73%
3.9M
-30.45%
5.6M
+15.09%
4.8M
N/A
Retained Earnings
-81.3M
+18.26%
-68.7M
+24.83%
-55.1M
+39.45%
-39.5M
N/A
Total Stockholders Equity
N/A
N/A
6.0M
+667.48%
778,000
-87.56%
6.3M
N/A
Total Shares Outstanding
10.9M
+245.71%
3.1M
+20.71%
2.6M
-76.86%
11.2M
N/A
Cash Flow
Cash from Operating Activities
-10.7M
+8.78%
-9.9M
-18.92%
-12.2M
+1.31%
-12.0M
N/A
Capital Expenditures
273,000
+46.77%
186,000
N/A
N/A
N/A
847,000
N/A
Cash from Investing Activities
-1.0M
+450.00%
-186,000
-103.03%
6.1M
+312.97%
-2.9M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
9.0M
-36.36%
14.1M
+124.14%
6.3M
-55.35%
14.1M
N/A
Financials Ratio
Gross Margin
59.79%
+14.51%
52.21%
+23.19%
42.38%
N/A
N/A
N/A
Operating Margin
-324.34%
-22.79%
-420.08%
-21.79%
-537.12%
N/A
N/A
N/A
Return on Assets
-121.89%
-27.85%
-168.93%
-5.49%
-178.74%
N/A
N/A
N/A
Return on Equity
N/A
N/A
-405.19%
-8.59%
-443.27%
N/A
N/A
N/A
Revenue Growth
20.35%
+70.76%
11.92%
-96.32%
323.73%
N/A
N/A
N/A
Current Ratio
2.11
-52.05%
4.39
+254.68%
1.24
N/A
N/A
N/A
Cash Ratio
1.17
-66.57%
3.50
+352.21%
0.77
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow